Skip to main content
Premium Trial:

Request an Annual Quote

Sirnaomics Partners with Chinese Pharma on Wound-Healing Drug

Premium

Sirnaomics said this week that it has signed a deal with an undisclosed Chinese pharmaceutical company to co-develop an siRNA-based drug for scarless wound healing.

The drug, STP705, uses a polymeric nanoparticle to enhance topical delivery of siRNAs targeting the TGF-beta 1 and Cox-2 genes to open wounds, Sirnaomics said.

The new alliance "provides financial resources and local capabilities allowing acceleration through the clinical study and regulatory process in China," the company added.

The arrangement, which includes "licensing, funding, and market-sharing structures," is limited to the greater China area, including Hong Kong, Macau, and Taiwan. Additional terms were not disclosed.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.